# Can Innate Immune Memory Be Reprogrammed?

**ABSURD HEALTH INSTITUTE — MEDICAL CONCEPT PAPERS · VOLUME SIX · PAPER 19**

**Research series:** Aging Immune System as Repair Organ

**Article URL upon publication:** https://absurd.health/research/volume-six/can-innate-immune-memory-be-reprogrammed/

**Abstract.** Innate immune cells can acquire lasting response changes through metabolic and epigenetic processes. This essay investigates whether maladaptive immune training contributes to age-related repair failure and whether it might be modified without compromising antimicrobial defenses. It distinguishes trained immunity from antigen-specific memory, ongoing infection and clonal blood-cell changes.

## Immunity does not begin from zero each morning

Innate cells can change their future responses after infection, vaccination, metabolic stress or inflammatory stimulation. The term *trained immunity* describes some lasting functional changes linked to metabolic and epigenetic reprogramming. Such adaptation can improve protection under some circumstances and contribute excessive inflammation under others. As immune function changes with age, the question becomes whether harmful acquired response patterns can be altered without erasing protective antimicrobial competence.

## What must be distinguished

Memory-like innate responses are not identical to conventional T- and B-cell antigen-specific memory. Nor is all chronic inflammation caused by trained immunity. Tissue-resident macrophages, circulating monocytes, marrow progenitors and local stromal cells can behave differently. An older host may simultaneously show insufficient responses to new pathogens and excessive basal inflammatory activity. 'Boosting immunity' and 'suppressing inflammation' therefore oversimplify a system whose successful function depends on discrimination, timing and resolution.

## A possible repair pathway

Innate cells participate in debris removal, angiogenesis and matrix remodeling. Reprogramming their response trajectory could theoretically improve healing if maladaptive inflammatory persistence is a true bottleneck. But changing the immune set point might also impair tumor surveillance or responses to infection. A useful intervention would need to show selective improvement in repair-related behavior rather than a nonspecific change in cytokine concentrations.

## Falsifiability and restraint

Evidence for a reversible trained state in a model is not proof that dietary supplements can reset immune memory in humans. The research challenge is distinguishing epigenetically sustained response patterns from ongoing antigen exposure, clonal hematopoiesis, obesity, medication effects and ordinary immune-cell turnover. The Institute's concept of immune permission is helpful only when it promotes these discriminations instead of becoming a catchall explanation for any inflammatory illness.

## A clinical thought experiment

An immune system can be both tired and irritable: weak responses to new pathogens may coexist with excessive inflammatory signaling at rest. This apparent paradox becomes less surprising when different cell populations and pathways are examined separately. A universal 'immune booster' would be an incoherent therapeutic target because it does not specify which function should rise and which should fall.

## What would discriminate among explanations

Evidence for useful reprogramming must show altered response to defined challenges without major loss of protective immunity. If inflammatory markers drop but infection susceptibility rises, the tradeoff matters. If metabolic changes follow rather than cause immune improvement, the causal account should be corrected instead of attributing every effect to epigenetic memory.

## Selected scientific readings

- López-Otín C et al. (2023). Hallmarks of aging: An expanding universe. Cell. https://doi.org/10.1016/j.cell.2022.11.001
- Jaiswal S et al. (2017). Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa1701719

*This is an evidence-informed conceptual essay, not a systematic review, clinical trial, validated diagnostic instrument, or treatment recommendation.*